Global FGFR Fibroblast Growth Factor Receptor Inhibitor Drug Market Clinical Trials Report 2026
09. August 2021 08:30 ET
|
KuicK Research
DELHI, India, Aug. 09, 2021 (GLOBE NEWSWIRE) -- “Global Fibroblast Growth Factor Receptor Inhibitor Drug Market Opportunity & Clinical Trials Insight 2026” Report Highlights: Global FGFR...
Global KRAS Inhibitor Drug Market Sales Size Clinical Trials Forecast Report 2026
03. Februar 2021 08:02 ET
|
KuicK Research
DELHI, India, Feb. 03, 2021 (GLOBE NEWSWIRE) -- "Global KRAS Inhibitors Market Opportunity & Clinical Trials Outlook 2025" Report Highlights: KRAS Inhibitors Market Opportunity: > USD 1...
Revolution Medicines Announces Dosing of First Patient in Phase 1b Combination Study of RMC-4630 and AMG 510
09. Juni 2020 07:30 ET
|
Revolution Medicines, Inc.
Study Evaluates Combination Treatment with Investigational SHP2 and KRASG12C Inhibitors in Patients with KRASG12C Mutant Solid Tumors REDWOOD CITY, Calif., June 09, 2020 (GLOBE NEWSWIRE) --...